JAK2 and thoracic aortic aneurysm: <b>Conclusions:</b> Compelling emerging evidence supports an association between the <i>JAK2</i> V617F somatic mutation and the formation of thoracic aortic aneurysms, with VAF acting as a valuable biomarker for aneurysm risk.